Paushak Ltd

Paushak Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Paushak Ltd

₹ 731 -1.82%
17 Oct 4:01 p.m.
paushak.com BSE: 532742
About

Paushak is India’s largest phosgene based specialty chemicals manufacturer serving pharmaceutical, agrochemical and performance industries. Paushak is part of the Alembic group of companies situated in Gujarat, India.. Alembic Ltd is the oldest pharmaceutical company in India founded in 1907. [1][2]

Key Points

Products Offered
Paushak is part of the Alembic group of companies situated in Gujarat, India and is the largest specialty chemical company in India based on Phosgene Chemistry. Its products include Chloroformates, Isocyanates, Chlorides, Carbonates/Carbamate and Other Chemicals. These chemicals are used in diverse fields such as pesticides, pharmaceuticals dyes plastics and perfumeries. [1] [2]

Website BSE
  • Market Cap ₹ 1,802 Cr.
  • Current Price ₹ 731
  • High / Low ₹ 991 / 468
  • Stock P/E 35.3
  • Book Value ₹ 189
  • Dividend Yield 0.34 %
  • ROCE 11.2 %
  • ROE 9.76 %
  • Face Value ₹ 5.00
Edit ratios

Pros

  • Company is almost debt free.

Cons

  • The company has delivered a poor sales growth of 8.87% over past five years.
  • Company has a low return on equity of 12.3% over last 3 years.
  • Dividend payout has been low at 11.3% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
50 50 56 56 49 52 52 54 52 57 49 52 56
32 33 35 37 36 38 33 35 40 40 35 36 38
Operating Profit 18 17 20 20 12 14 19 19 12 17 15 16 18
OPM % 37% 33% 37% 35% 25% 28% 36% 35% 23% 30% 30% 30% 32%
1 5 3 2 4 7 3 7 4 4 6 0 2
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 3 3 3 3 3 3 3 4 4 4 4 4 4
Profit before tax 16 18 20 19 12 18 18 23 12 17 17 12 16
Tax % 27% 27% 24% 23% 26% 25% 26% 19% 17% 16% 11% 21% 23%
12 13 15 14 9 13 14 18 10 14 15 10 12
EPS in Rs 4.70 5.32 6.11 5.83 3.72 5.42 5.54 7.42 4.19 5.77 6.20 3.90 4.89
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
54 69 78 72 105 140 138 141 150 212 206 211 215
43 52 61 60 75 99 95 91 96 137 142 151 149
Operating Profit 11 17 17 12 29 40 43 50 54 75 65 60 65
OPM % 20% 25% 22% 17% 28% 29% 31% 36% 36% 35% 31% 28% 30%
4 3 3 5 3 13 7 6 5 11 20 14 12
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 2 2 3 3 3 4 4 5 9 13 14 15 15
Profit before tax 13 18 17 14 29 49 45 52 50 72 71 59 62
Tax % 30% 28% 25% 22% 26% 20% 23% 28% 25% 25% 23% 16%
9 13 12 11 21 39 35 37 38 54 54 49 51
EPS in Rs 3.45 5.07 4.85 4.27 8.39 15.84 14.19 15.16 15.29 21.96 22.09 20.07 20.76
Dividend Payout % 11% 7% 8% 9% 4% 4% 5% 5% 10% 10% 11% 12%
Compounded Sales Growth
10 Years: 12%
5 Years: 9%
3 Years: 12%
TTM: 2%
Compounded Profit Growth
10 Years: 14%
5 Years: 6%
3 Years: 5%
TTM: -8%
Stock Price CAGR
10 Years: 18%
5 Years: 10%
3 Years: -12%
1 Year: 9%
Return on Equity
10 Years: 14%
5 Years: 13%
3 Years: 12%
Last Year: 10%

Balance Sheet

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 3 3 3 3 3 3 3 3 3 3 3 3
Reserves 42 54 65 80 110 174 224 269 302 351 405 462
0 0 1 0 1 0 0 0 0 0 0 25
8 11 13 11 31 36 43 57 61 61 73 81
Total Liabilities 54 69 82 94 144 214 270 329 367 415 481 572
9 18 20 35 37 38 41 51 147 149 152 141
CWIP 4 1 12 0 1 6 16 68 8 7 29 190
Investments 18 19 18 33 53 116 163 154 151 182 223 139
23 30 31 26 54 54 50 56 61 78 77 102
Total Assets 54 69 82 94 144 214 270 329 367 415 481 572

Cash Flows

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
9 9 14 12 10 24 45 30 44 43 56 38
-7 -8 -13 -11 -10 -0 -43 -29 -42 -38 -50 -57
-2 -1 -1 -2 -1 -23 -2 -2 -2 -4 -5 19
Net Cash Flow 0 0 0 -0 0 0 0 -1 -0 0 0 -1

Ratios

Figures in Rs. Crores

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 96 114 97 83 135 85 69 85 97 90 90 94
Inventory Days 117 96 117 125 118 122 131 148 233 180 177 179
Days Payable 71 94 104 70 170 73 110 118 227 122 130 167
Cash Conversion Cycle 142 116 110 138 83 133 89 115 103 149 137 107
Working Capital Days 108 108 92 92 107 100 75 60 81 93 84 80
ROCE % 30% 32% 25% 12% 29% 27% 21% 20% 17% 21% 17% 11%

Shareholding Pattern

Numbers in percentages

1 Recently
Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Oct 2025
66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 66.97% 67.14% 67.14% 67.28% 67.28%
0.01% 0.02% 0.02% 0.02% 0.02% 0.00% 0.00% 0.00% 0.01% 0.00% 0.00% 0.00%
0.00% 0.00% 0.00% 0.11% 0.20% 0.29% 0.34% 0.39% 0.53% 0.53% 0.70% 0.70%
33.01% 33.01% 33.02% 32.89% 32.81% 32.74% 32.70% 32.64% 32.33% 32.34% 32.02% 32.02%
No. of Shareholders 19,43520,22821,46821,59222,50321,55021,47320,74820,28620,17522,01321,084

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings